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Biocompatible porous carbons can be used for the purification of various bio-
fluids, including the cleansing blood of inflammatory mediators in conditions 
such as sepsis or auto-immune diseases. Here we show that the control of pore 
size in carbons is a key factor to achieving efficient removal of cytokines. In 
particular, the surface area accessible by the protein governs the rate and 
effectiveness of the adsorption process. We demonstrate that novel mesoporous 
carbon materials synthesized from ternary MAX-phase carbides can be optimized 
for efficient adsorption of large inflammatory proteins. The synthesized carbons, 
having tunable pore size with a large volume of slit-shaped mesopores, 
outperformed all other materials or methods in terms of efficiency of TNF-Į
removal and the results are comparable only with highly specific antibody-antigen 
interactions.
2The worldwide occurrence of sepsis with over 18 million cases recorded annually 
and the absence of efficient drug-based therapies, make this systemic inflammatory 
response to infection one of the leading causes of death (1). Severe sepsis, which 
accounts for over 17 % of the total sepsis cases, and having a current mortality rate 30-40 
%, is responsible for the death of 1,500 people/day worldwide, on a scale comparable to 
lung and breast cancer (~ 2,700 and ~ 1,100 people /day, respectively) (1,2). From an 
economic perspective, sepsis places a significant burden on healthcare systems, costing 
over $ 17 billion / year in the US alone (3). The inflammatory response to various bodily 
insults is driven by a complex network of inflammatory mediators, these consist mainly 
of proteins called cytokines (4-6). Cytokine removal from blood may help to bring under 
control the unregulated pro- and anti-inflammatory processes driving sepsis. Therapies 
aimed at the simultaneous reduction of cytokines across a wide range of molecular sizes 
might, therefore, prove more effective than drugs directed against a single or a few 
inflammatory mediators (5-7). Hemofiltration or hemoadsorption could allow 
extracorporeal removal of these inflammatory cytokines to an extent that is sufficient to 
strongly reduce the inflammatory response. While both sieving and adsorption could play 
a role in hemofiltration, the adsorption characteristics of the filter material are generally 
believed to be a dominant factor in membrane efficiency. Adsorption can remove toxins 
without introducing other substances into the blood. Therefore, hemoadsorption might 
have advantages over hemofiltration, having the same or better efficiency in the treatment 
of inflammatory diseases, being of lower cost and offering considerably better comfort 
for patients during and after the treatments (8).  
3Activated carbons (ACs), known for over three thousand years, still remain the 
most powerful conventional adsorbents (8), mainly due to their highly developed porous 
structure and large surface area. Most of the specially purified ACs prepared from 
synthetic polymers show excellent biocompatibility and do not require special coatings 
for direct contact with blood (8,9). However, despite extensive studies and improvements 
in the activation processes, little control over the pore structure has been achieved. Even 
advanced ACs show limited performance in adsorbing large inflammatory proteins, 
mostly due to the limited surface area accessible to the adsorbate. Templating has 
previously been used to increase the volume fraction of the larger pores (10-12). For 
example, porous carbon was prepared by introducing carbon into the pores of alumina or 
silica substrates and subsequently dissolving the oxide template by acidic treatment. 
Apart from cost issues, the resulting carbon generally demonstrates poor mechanical 
integrity and near-spherical shape of the pores with the bottlenecks that do not allow 
large molecules to be adsorbed inside the bulk of the particles. In principle, it follows that 
interconnected slit-shaped pores of an optimized size would be more advantageous for 
the discussed application. Small particles (< 100 nm) would offer a larger external 
surface, but they cannot be used in most of the biomedical applications due to difficulties 
of filtering them from the biofluids. The pore size in other porous carbon materials, such 
as carbon nanotubes (CNT), is very difficult to control and tune to the desired values. 
Most CNTs have a low specific surface area (SSA) and agglomeration of CNT into ropes, 
particularly when they are brought in contact with biofluids, generally significantly 
reduces their accessible surface area.  
4Carbon produced by etching of metal(s) from metal carbides and called carbide 
derived carbon (CDC) has recently been shown to offer great potential for controlling the 
size of micropores (0.4 – 2 nm) (13). CDCs are generally produced by chlorination of 
carbides in the 200-1200°C temperature range. Metals and metalloids are removed as 
chlorides, leaving behind a collapsed noncrystalline carbon with up to 80% open pore 
volume. The detailed nature of the porosity - average size and size distribution, shape, 
and total specific surface area (SSA) - can be tuned with high sensitivity by the judicious 
selection of the precursor carbide (composition, lattice type, etc.) (13-16) and 
chlorination temperature (13). However, only tuning of microporosity (0.4-2 nm) has 
been demonstrated in CDCs so far. In this paper we demonstrated a method to produce 
porous carbons with controlled volume and surface area of slit-shaped mesopores (2-50 
nm) of certain size by CDC synthesis from selected ternary (MAX-phase) carbides (17) 
and investigated the effect of pore structure on removal of cytokines from blood.  
Results and discussion 
Porosity characterization. Figure 1 shows the N2 sorption isotherms of CDCs (Fig. 1A) and 
commercial carbon samples (Fig. 1B). All the samples, except Adsorba 300C, 
demonstrate type IV isotherm according to the Brunauer classification (18) with a 
characteristic hysteresis, suggesting the presence of mesopores (pores with size in the 2-
50 nm range). CDCs from both Ti2AlC (Fig. 1A) and Ti3AlC2 (not shown) demonstrate 
similar trends as the temperature of synthesis changes. The volume of N2 adsorbed in the 
porous structure of CDC prepared at lower temperature (600 °C) approaches half of the 
maximum values at low relative pressure (P/P0). The steep slope of the adsorption curve 
at P/P0 values approaching 1, associated with capillary condensation in mesopores, is 
5quite short, suggesting a small mesopore volume (1 9 ) . The N2 sorption behavior 
changes dramatically at intermediate (~ 800 °C) chlorination temperatures. The total 
volume of adsorbed N2 more than doubles; an increase is observed over the whole P/P0
range, indicating a significant increase in both the total and mesopore volume. The level 
of adsorption-desorption hysteresis, and the steep slope as P/P0 approaches unity also 
increases substantially, in agreement with the suggested increase in the relative volume of 
mesopores. As the synthesis temperature increases to 1200 °C, the volume of adsorbed 
N2 further increases in the P/P0 range of up to ~ 0.8, but becomes lower at higher P/P0
values (Fig. 1A). Such changes in the isotherm shape indicate the reduction in the relative 
volume of larger mesopores.  
The pore size distribution (PSD) curves calculated in the 1.5-36 nm range for all 
the studied samples from the N2 isotherms (Fig. 2) fully support the aforementioned 
conclusions. The CDC samples formed at low temperature (600° C) have a very low 
volume of mesopores, particularly those above 10 nm (Figs. 2B and 2F). At the 
intermediate synthesis temperatures (800° C), the PSD becomes wider and shifts to 
higher pore-size values (Figs. 2C and 2G). These samples clearly have the largest volume 
of mesopores above 5 nm. At the high chlorination temperature of 1200 °C the total CDC 
mesopore volume remains relatively high (Fig. 2D and 2H). It is in fact higher than the 
total pore volume of many activated carbon samples, including Adsorba 300C (Fig. 2A). 
However, most of the mesopores in these samples are below 4-5 nm. Adsorba 300C has 
the smallest volume of mesopores and is almost purely microporous carbon. The PSD of 
the CXV sample (Fig. 2E) is close to that of an average of CDC samples produced at high 
6and intermediate temperatures. The porosity data for all the studied samples are 
summarized in Table S1 (Supplementary Information).  
While Ar sorption is not a very efficient technique to study the large mesopores, it 
gives more accurate PSD results for small (< 4 nm) pore values, mainly due to argon’s 
smaller atomic size, the absence of quadrupole moment (which can potentially lead to 
localized adsorption as in case of N2) and its weaker interactions with carbon adsorbents. 
The PSD of the studied samples in the 0.4 - 4 nm range obtained from Ar sorption 
isotherms (Supplementary Information, Fig. S1) revealed details of the samples’ 
microporosity. Similar to Adsorba 300C, both CDC samples produced at 600 °C have the 
majority of pores below 2 nm in width. As the CDC synthesis temperature increases, the 
average size of the pores in the 0.4 - 4 nm range increases as well (Fig. S1). However, 
above 800 °C, pores in the 2-4 nm range have a tendency to grow on the account of the 
micropores, forming a large volume of ~ 3 nm pores at 1200 °C. The PSD of the CXV 
sample is close to the average between the CDC samples formed at 800 and 1200 °C.  
Transmission electron microscopy. Transmission electron microscopy (TEM) revealed 
disordered microstructure of all the studied carbons. The degree of disorder was different 
between the carbons. Both CDCs formed at 600 °C demonstrate completely amorphous 
structure, without any graphite fringes visible (Fig. 3A). Increasing the CDC processing 
temperature to 800 °C resulted in the formation of short curved graphene structures, 
considered turbostratic carbon (Fig. 3B). At 1200 °C TEM detected markedly increased 
ordering and the formation of long and thin (1-3 graphene sheets) graphite ribbons (Fig. 
3C). At the edge of the particles, ribbons with up to 10 graphene layers were found (Fig. 
73C). The microstructure of Adsorba 300C sample was found to be highly amorphous, 
(Fig. 3D) while that of the CXV carbon (Fig. 3E), turbostratic. 
Our previous studies have shown that the observed evolution of ordering within 
the carbon structure with the chlorination temperature is quite common for most of the 
CDCs obtained from both ternary and binary carbides (20). The changes in the PSDs 
correlate to changes in the CDC microstructure. The low mobility of the carbon atoms at 
the low chlorination temperatures resulted in the formation of a uniform amorphous 
structure (Fig. 3A) with small micropores (Figs. 2B, 2F, S1B, S1F). At higher synthesis 
temperatures, higher carbon mobility allowed for the formation of graphitic ribbon 
networks (Fig. 3C), with mesopores forming between the graphene ribbons and 
micropores in the imperfections of the graphitic ribbons or within the remaining 
disordered carbon (Figs. 2D, 2H, 1SD, 1SH). At the intermediate temperature of 800 °C, 
the mobility of carbon was high enough to allow for a redistribution of carbon atoms into 
defective graphene sheets and the collapse of several sheets into stacks forming 
mesopores between them. However, the mobility was still too low to allow uniform 
linking between the turbostratic ribbons, resulting in a wide distribution of mesopores 
(Figs. 2C, 2G). Note, that since precise determination of non-spherical pores in 
disordered non-planar particles is not possible using TEM, we relied on gas sorption 
measurements for the PSD determination. 
Cytokine adsorption. Figure 4 compares efficiency of removal of two selected cytokines 
(tumor necrosis factor alpha (TNF-Į) and interleukin-6 (IL-6)) from human plasma using 
the investigated carbons. Adsorption of TNF-Į is known to be the most challenging task, 
probably due to a large size (> 9.4 nm) of the trimeric (most common) form of this 
8cytokine (21). Adsorba 300C and CDC produced at 600°C, which have small pores, did 
not noticeably change the protein concentration over time. CDC produced at 1200 °C and 
CXV also demonstrated a limited success in the adsorption of TNF-Į, decreasing its 
concentration by about 40 % after one hour of adsorption (Fig. 4A), similar to that 
observed in advanced porous carbon hemoadsorption systems (22). In contrast, both CDC 
samples prepared at 800 °C decreased the protein concentration by over 13 times in this 
time period. To the best of our knowledge, in these experiments CDCs outperformed any 
other material or method for the efficient removal of TNF-Į, and the results are 
comparable only to highly specific antibody-antigen interactions (23, 24).
Adsorption of the smaller cytokine IL-6 by most of the studied carbons was 
noticeably higher, but demonstrated similar trends (Fig. 4B). Strictly microporous 
Adsorba 300C was clearly inefficient. However, CDCs prepared at 600 °C, having a 
limited amount of mesopores (pores 2-50 nm), adsorbed 66 to 77 % of the cytokines 
initially present in the solution in one hour. The CDCs produced at 1200° C demonstrated 
97-98.5 % adsorption, which is comparable to the CXV sample, capable of adsorbing ~ 
99 %. The CDCs prepared from Ti2AlC at 800 °C, having the most developed 
mesoporosity decreased IL-6 concentration by ~ 99.8 %; the remaining IL-6 was close to 
the detection limit of the ELISA used.  
A clear dependence of protein removal efficiency on the PSDs of the porous 
carbons is seen when protein adsorption is plotted as a function of the carbons’ accessible 
surface area, which is approximated as the SSA of pores exceeding the smallest protein 
dimension in size (Fig. 5). Dimensions of the investigated cytokines were considered to 
be: 9.4 x 9.4 x 11.7 nm (trimer of TNF-Į) (21), 5.5 x 5.5 x 7.7 nm (IL-1ȕ) (25), 5 x 5 x 
912.2 nm (IL-6) (26), 4 x 4 x 9 nm (IL-8) (27). The larger the surface areas of the porous 
carbons accessible to a given cytokine (SSAacc), the more cytokines were adsorbed at a 
given time (Figs. 5A, 5B, 5C, 5D). Some scattering in the results obtained could be 
explained by experimental errors in the estimation of the cytokine concentration and the 
carbon PSD. Depending on the cytokine and its initial concentration, values of the SSAacc
above 50-100 m2/g were generally sufficient for fast and efficient cytokine removal. The 
relatively short and small IL-1ȕ and IL-8 cytokines diffused so rapidly into the carbon 
pores that 5 min was sufficient to adsorb most of these proteins by carbons with SSAacc 
exceeding 50 m2/g (Figs. 5B and 5D). The existence of larger channels within these 
carbons should have further accelerated the adsorption process. IL-6 demonstrated slower 
adsorption (Fig. 5C), probably due to its longer dimensions and hence slower diffusion 
within the carbon pore structure. The TNF-Į trimer, the largest adsorbate, demonstrated a 
further decrease in adsorption rate (Fig. 5A) as the amount of pores, exceeding three 
times the adsorbate size needed for fast diffusion, was limited (Figs. 2C and 2G).  
Historically, in medical sciences and applied medicine, activated carbons are 
considered to be high SSA carbons of ultra purity. Differentiation of activated carbons 
with respect to difference in their PSD is uncommon. In fact, the same carbon materials 
are often used for adsorption of various species, from gases to organic molecules. 
However, since most commercial medical grade activated carbons, including Adsorba, 
are primarily microporous (Figs. 2A, 1SA), adsorption of inflammatory mediators with 
size exceeding 2 nm could only take place on the particles’ surface (Fig. 6A). The 
calculated SSA of spherical carbon particles with a 10 μm diameter and 50 % porosity is 
only ~ 0.3 m2/g, which is much smaller than the 386 - 406 m2/g SSA of mesopores (2-50 
10
nm) in the CDCs produced at 800 °C. It is thus not too surprising that clinical trials of 
commercial extracorporeal adsorption systems did not show significantly decreased 
mortality in patients with sepsis (28,29). Large biological molecules can move through 
pores of appropriate size, as translocation of DNA through a nanotube demonstrated 
recently (30), and be adsorbed in the bulk of the adsorbent particles (Fig. 6B). Pore size 
control is thus a key issue for achieving highly-efficient removal of large cytokines from 
blood plasma. Engineering of novel nanostructured CDC adsorbents, with rationally 
optimized porosity may provide a solution for extracorporeal adsorption systems and 
save the lives of people suffering severe sepsis. Similar approaches could be used for the 
selective adsorption of other large organic molecules and possibly viruses for other bio-
related or medical applications.  
The CDC method presented here, together with the unique layered structure of the 
ternary MAX-phase carbide precursors used here, has made it possible to synthesize 
mesoporous carbons with large volumes and surface areas of slit-shaped mesopores. 
Based on this work it appears that not only micropores (0.4-2 nm) but also mesopores (2-
50 nm) can be tuned in a controlled way by extraction of metals from carbides, providing 
a mechanism for the optimization of adsorption systems for selective sorption of a large 
variety of biomolecules.  
Materials and Methods 
Materials. CDCs were synthesized from commercially available (3-ONE-2, Inc, NJ, US) 
and produced at Drexel University powders of Ti2AlC and Ti3AlC2 by the reaction with 
pure chlorine (99.5%, BOC gases) at 600, 800 and 1200°C. Both carbides belong to the 
MAX-phase group of ternary carbides, having a layered hexagonal structure with carbon 
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atoms positioned in basal planes and separated by 0.68 nm (Ti2AlC) or alternating layers 
of 0.31 and 0.67 nm (Ti3AlC2) (31). The CDCs produced from these carbides are known 
to posses slit-shaped open pores (13,32,33). The average particle size of the carbide 
samples used in our experiments was a 10 μm, as measured using a particle size analyzer 
(Horiba LA-910, Japan). For CDC synthesis, the selected carbide powder was placed 
onto a quartz sample holder and loaded into the hot zone of a horizontal quartz tube 
furnace. Prior to heating, the tube (a 30 mm in diameter) was purged with high purity Ar 
(BOC Gases, 99.998%) for 30 minutes at a flow rate of 100 sccm. Once the desired 
temperature was reached and stabilized, the Ar flow was stopped and a 3-hour 
chlorination began with Cl2 flowing at a rate of 10 sccm.  After the completion of the 
chlorination process, the samples were cooled down under a flow of Ar (40 sccm) for 
about five hours to remove any residual chlorine or metal chlorides from the pores, and 
taken out for further analyses. In order to avoid a back-stream of air, the exhaust tube was 
connected to a bubbler filled with sulphuric acid. A detailed description of the 
chlorination apparatus used in this study can be found elsewhere (20). 
The sorption performance of the CDCs was compared with that of Adsorba 300C 
and CXV carbon adsorbents. Adsorba 300C is an activated carbon produced by Norit 
from peat, and coated with a 3-5 μm thick cellulose membrane for better 
hemocompatibility. It is commercially used in adsorbent-assisted extracorporeal systems 
manufactured by Gambro, Sweden. CXV is an activated carbon obtained from CECA 
(subsidiary of Arkema, France), known to be extremely efficient for cytokine removal 
applications and thus used as a benchmark reference. 
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Characterization. The structure of the CDCs was investigated using high-resolution 
transmission electron microscopy (HRTEM). The TEM samples were prepared by two 
minutes sonication of the CDC powder in isopropanol and deposition on the lacey-carbon 
coated copper grid (200 mesh). A field-emission TEM (JEOL 2010F, Japan) with an 
imaging filter (Gatan GIF) was used at 200 kV.  
The porosity of CDCs was studied using automated micropore gas analyzers 
Autosorb-1 and Nova (Quantachrome Instruments, USA). The N2 and Ar sorption 
isotherms were obtained at liquid nitrogen temperature (-196 oC) in the relative pressure 
P/P0 range of about 8·10-7 to 1 and 2·10-2 to 1, respectively. The isotherms were analyzed 
using Brunauer–Emmet-Teller (BET) equation and non-local density functional theory 
(NLDFT) (18,19,34,35) to reveal the SSA and pore-size distributions (PSD) of the CDCs. 
The SSAs calculated using BET and DFT theory are referred to as BET-SSA and DFT-
SSA, respectively. A difference in absolute values between BET-SSA and DFT-SSA is 
expected, as both types of calculations are based on different assumptions, which might 
not be justified with the utmost accuracy for all the materials under study. Quantachrome 
Instruments data reduction software Autosorb v.1.50 (1 9 )  was employed for the porosity 
analysis. Slit-shaped pores were assumed for the calculations. 
Cytokine adsorption experiments. Fresh frozen human plasma (NBS, UK) was 
defrosted and spiked with the recombinant human cytokines (TNF-Į, IL-1ȕ, IL-6, and IL-
8; all obtained from BD Biosciences, US) at a concentration of about 1000, 500, 5000, 
and 500 pg/ml, respectively. These levels are comparable with the concentrations 
measured in the plasma of patients with sepsis (36-38). Carbon adsorbents (0.02 g) were 
equilibrated in phosphate buffered saline (PBS) (0.5 ml) overnight prior to removal of 
13
PBS and addition of 800 μl of spiked human plasma. Controls consisted of spiked plasma 
with no adsorbent present. Adsorbents were incubated at 37 qC while shaking (90 rpm). 
At 5, 30 and 60 min time points, samples were centrifuged (125g) and the supernatant 
collected and stored at -20 °C prior to ELISA (BD Biosciences) analysis for the presence 
of cytokines. Samples were diluted 1:4 (TNF-D, IL-8, IL-1ȕ) and 1:10 (IL-6) in assay 
diluent prior to analysis. 
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Fig. 1. Nitrogen sorption isotherms. (A) Ti2AlC CDC, (B) CXV and Adsorba samples. N2 isotherms 
for Ti3AlC2 CDC are very similar to the isotherms for Ti2AlC CDC synthesized at identical 
temperatures.
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Fig. 2. Distribution of pore sizes of porous carbons in the 1.5 - 36 nm range obtained from N2
sorption isotherms. (A) Adsorba, (B-D) CDC produced from Ti3AlC2 at 600, 800, and 1200° C, (E) 
CXV, (F-H) CDC produced from Ti2AlC at 600, 800, and 1200° C.
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Fig. 3. Transmission electron microscopy of porous carbon samples. (A-C) CDC produced 
from Ti2AlC at 600, 800, and 1200° C, (D) Adsorba, (E) CXV. The structure of Ti3AlC2 CDC 
replicates the one for Ti2AlC CDC if synthesized at identical temperatures. Scale bar = 5 nm. 
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Fig. 4. Comparison of the porous carbons efficiency in the cytokine removal from human blood 
plasma. (A) Concentration of TNF-Į in the plasma solution initially and after 5, 30, and 60 minutes 
of adsorption. (B) Similar changes in IL-6 concentration. Both CDC samples produced at 800° C 
and having developed mesoporosity outperformed other materials in the efficiency of cytokines 
removal.
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Fig. 5. Adsorption of cytokines by porous carbons as a function of the surface area accessible to 
the cytokines. (A) TNF-D, (B) IL-1ȕ, (C) IL-6, (D) IL-8. The accessible area is approximated as the 
SSA of pores exceeding the smallest protein dimension in size: 9.4 nm for TNF-D trimer, 5.5 nm 
for IL-1ȕ, 5 nm for IL-6, and 4 nm for IL-8. Amount of the adsorbed cytokines was measured after 
5, 30, and 60 min adsorption. Larger carbon surface area accessible to the cytokines clearly results 
in faster and more complete adsorption. The horizontal dotted black line on the top of each graph 
indicates the initial concentration of the cytokines in plasma.
A                            B  
C                                     D 
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Fig. 6. Schematics of protein adsorption by porous carbons. (A) Surface adsorption in microporous 
carbon. Small pores do not allow proteins (shown in pink) to be adsorbed in the bulk of carbon 
particles (shown in blue). (B) Adsorption in the bulk of mesoroporous CDC. Large mesopores are 
capable to accommodate most of the proteins. Carbon particles are shown in cross-section.  
Alignment of the slit-shaped pores drawn in both illustrations is a simplification. 
proteins adsorbed on the surface proteins adsorbed on the surface 
and in the mesopores 
microporous carbon mesoporous CDC10 nm 10 nm 
A                                 B 
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Fig. S1. Distribution of pore sizes of porous carbons in the 0.4 - 4 nm range obtained from argon 
sorption isotherms. (A) Adsorba, (B-D) CDC produced from Ti3AlC2 at 600, 800, and 1200° C, (E) 
CXV, (F-H) CDC produced from Ti2AlC at 600, 800, and 1200° C. The minima at pore size of ~ 1 
and 2.5 nm are artifacts of the NLDFT model. 
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Table.S1. Porosity of the carbon samples obtained from N2 sorption measurements. Results are 
presented with respect to the samples’ surface area and pore volume accessible to the cytokines 
to be adsorbed. Such surface area and pore volume are approximated as the SSA and volume of 
pores exceeding the smallest protein dimension in size: 9.4 nm for TNF-Į trimer, 5.5 nm for IL-1ȕ,
5 nm for IL-6, and 4 nm for IL-8. 
Adsorba CXV 
Ti3AlC2 -
CDC,
600°C
Ti3AlC2 -
CDC,
800°C
Ti3AlC2 -
CDC,
1200°C
Ti2AlC-
CDC,
600°C
Ti2AlC-
CDC,
800°C
Ti2AlC-
CDC,
1200°C
BET-SSA, m2/g 1589 1652 1285 920 1493 1348 1649 2100 
DFT-SSA, m2/g 1362 1025 940 727 1037 1330 1412 1856 
SSA of pores above 9.5 
nm,  m2/g 0.76 14.6 8.53 98.2 30.7 12 95 48 
SSA of pores above 5.5 
nm, m2/g 1.1 98.3 17.2 201 61.3 24.7 193 77 
SSA of pores above 5.0 
nm, m2/g 1.12 120 20 223 67.6 29.1 224 88 
SSA of pores above 4.0 
nm, m2/g 5.98 172 36.5 291 84.7 59.4 296 107 
Total pore volume,  cc/g 0.639 1.270 0.705 1.70 1.24 0.825 2.17 2.01 
Volume of pores above 
9.5 nm, cc/g 0.0068 0.0824 0.074 0.781 0.257 0.104 0.817 0.497 
Volume of pores above 
5.5 nm, cc/g 0.0081 0.377 0.105 1.163 0.370 0.152 1.2065 0.611 
Volume of pores above 
5.0 nm, cc/g 0.0082 0.434 0.113 1.221 0.387 0.164 1.292 0.641 
Volume of pores above 
4.0 nm, cc/g 0.0188 0.554 0.149 1.373 0.425 0.232 1.45 0.685 
